156 related articles for article (PubMed ID: 22149316)
1. Apolipoprotein E mimetics and cholesterol-lowering properties.
Sharifov OF; Nayyar G; Garber DW; Handattu SP; Mishra VK; Goldberg D; Anantharamaiah GM; Gupta H
Am J Cardiovasc Drugs; 2011 Dec; 11(6):371-81. PubMed ID: 22149316
[TBL] [Abstract][Full Text] [Related]
2. Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.
Nayyar G; Handattu SP; Monroe CE; Chaddha M; Datta G; Mishra VK; Keenum TD; Palgunachari MN; Garber DW; Anantharamaiah GM
Atherosclerosis; 2010 Dec; 213(2):449-57. PubMed ID: 21030022
[TBL] [Abstract][Full Text] [Related]
3. Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo.
Datta G; Garber DW; Chung BH; Chaddha M; Dashti N; Bradley WA; Gianturco SH; Anantharamaiah GM
J Lipid Res; 2001 Jun; 42(6):959-66. PubMed ID: 11369804
[TBL] [Abstract][Full Text] [Related]
4. The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts.
Datta G; Chaddha M; Garber DW; Chung BH; Tytler EM; Dashti N; Bradley WA; Gianturco SH; Anantharamaiah GM
Biochemistry; 2000 Jan; 39(1):213-20. PubMed ID: 10625496
[TBL] [Abstract][Full Text] [Related]
5. Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.
Handattu SP; Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Mishra VK; Datta G; Anantharamaiah GM
Atherosclerosis; 2013 Mar; 227(1):58-64. PubMed ID: 23159231
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2).
Datta G; White CR; Dashti N; Chaddha M; Palgunachari MN; Gupta H; Handattu SP; Garber DW; Anantharamaiah GM
Atherosclerosis; 2010 Jan; 208(1):134-41. PubMed ID: 19656510
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
Anantharamaiah GM; Garber DW; White CR
Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.
Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Handattu SP; Mishra VK; Anantharamaiah GM
Atherosclerosis; 2012 Oct; 224(2):326-31. PubMed ID: 22771190
[TBL] [Abstract][Full Text] [Related]
9. Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice.
Garber DW; Handattu S; Aslan I; Datta G; Chaddha M; Anantharamaiah GM
Atherosclerosis; 2003 Jun; 168(2):229-37. PubMed ID: 12801605
[TBL] [Abstract][Full Text] [Related]
10. Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques.
Anantharamaiah GM; Garber DW; Goldberg D; Morrel E; Datta G; Palgunachari MN; Register TC; Appt SE; White CR
J Lipid Res; 2018 Nov; 59(11):2075-2083. PubMed ID: 30201630
[TBL] [Abstract][Full Text] [Related]
11. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.
Ji ZS; Brecht WJ; Miranda RD; Hussain MM; Innerarity TL; Mahley RW
J Biol Chem; 1993 May; 268(14):10160-7. PubMed ID: 7683668
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Marais AD
Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
[TBL] [Abstract][Full Text] [Related]
13. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
Ji ZS; Fazio S; Mahley RW
J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-β pathology.
Handattu SP; Monroe CE; Nayyar G; Palgunachari MN; Kadish I; van Groen T; Anantharamaiah GM; Garber DW
J Alzheimers Dis; 2013; 36(2):335-47. PubMed ID: 23603398
[TBL] [Abstract][Full Text] [Related]
15. Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.
Sharifov OF; Nayyar G; Ternovoy VV; Palgunachari MN; Garber DW; Anantharamaiah G; Gupta H
Innate Immun; 2014 Nov; 20(8):867-80. PubMed ID: 24323453
[TBL] [Abstract][Full Text] [Related]
16. Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice.
Auger A; Truong TQ; Rhainds D; Lapointe J; Letarte F; Brissette L
Eur J Biochem; 2001 Apr; 268(8):2322-30. PubMed ID: 11298750
[TBL] [Abstract][Full Text] [Related]
17. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
18. Sustained-delivery of an apolipoprotein E-peptidomimetic using multivesicular liposomes lowers serum cholesterol levels.
Ramprasad MP; Anantharamaiah GM; Garber DW; Katre NV
J Control Release; 2002 Feb; 79(1-3):207-18. PubMed ID: 11853932
[TBL] [Abstract][Full Text] [Related]
19. The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease.
Valanti EK; Chroni A; Sanoudou D
Curr Opin Lipidol; 2019 Aug; 30(4):326-341. PubMed ID: 31157629
[TBL] [Abstract][Full Text] [Related]
20. The significance of apolipoprotein E structure to the metabolism of plasma triglyceride-rich lipoproteins.
Dergunov AD; Rosseneu M
Biol Chem Hoppe Seyler; 1994 Aug; 375(8):485-95. PubMed ID: 7811390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]